出 处:《中国医药指南》2022年第35期146-148,152,共4页Guide of China Medicine
摘 要:目的探讨重症急性胰腺炎患者在接受肠内营养支持治疗期间配合给予综合护理干预可行性。方法将我院2018年5月至2020年4月收治的66例重症急性胰腺炎患者采用数字奇偶法进行分组,观察组(33例)采用常规护理+综合护理干预方式配合完成肠内营养支持治疗,对照组(33例)采用常规护理方式配合完成肠内营养支持治疗;就组间营养支持疗效数据、血糖水平、白蛋白(ALB)、血红蛋白(Hb)、住院时间、不良反应(肝功能损伤、腹泻腹胀以及腹腔感染)发生情况、心理状态评分(SDS、SAS评分)展开对比。结果观察组重症急性胰腺炎患者营养支持有效率(90.91%)高于对照组(54.55%)明显(P<0.05);观察组重症急性胰腺炎患者血糖(18.03±1.35)mmol/L、ALB(37.19±5.25)g/L同对照组(17.92±1.49)mmol/L以及(36.79±6.13)g/L比较差异无统计学意义(P>0.05);观察组重症急性胰腺炎患者Hb(94.13±20.35)g/L、住院时间(24.25±5.39)d均低于以及短于对照组(105.39±24.19)g/L以及(31.19±4.52)d明显(P<0.05);两组重症急性胰腺炎患者不良反应主要集中于肝功能损伤、腹泻腹胀以及腹腔感染方面,最终发现观察组重症急性胰腺炎患者总不良反应率(6.06%)低于对照组(36.36%)明显(P<0.05);护理前,观察组SDS评分(55.25±2.53)分、SAS评分(55.66±3.28)分较对照组SDS评分(55.33±2.57)分、SAS评分(55.68±3.29)分差异无统计学意义(P>0.05);护理后,观察组SDS评分(22.25±3.18)分、SAS评分(23.37±3.19)分较对照组SDS评分(35.22±3.21)分、SAS评分(35.25±3.14)分更低(P<0.05)。结论综合护理干预于肠内营养支持中的配合应用,可使得重症急性胰腺炎患者营养支持疗效显著提升,将其Hb水平降低,将住院时间缩短,并可提升患者的治疗安全性,将患者焦虑症状以及抑郁症状有效缓解,最终实现重症急性胰腺炎患者的有效预后。Objective To investigate the feasibility of comprehensive nursing intervention for patients with severe acute pancreatitis during enteral nutrition support treatment.Methods From May 2018 to April 2020,66 cases of severe acute pancreatitis admitted to our hospital were divided into groups by digital parity method.The observation group(33 cases)were used routine nursing and comprehensive nursing intervention to complete enteral nutrition support treatment.The control group(33 cases)were used routine nursing with enteral nutrition support treatment.Intergroup nutritional support data,blood glucose levels,albumin(ALB),hemoglobin(Hb),length of stay,adverse events(liver function injury,diarrhea and abdominal distension,and abdominal infection)were compared.Results The effective rate of nutritional support in the observation group(90.91%)was significantly higher than that in the control group(54.55%)(P<0.05).There were no significant differences in blood glucose(18.03±1.35)mmol/L and ALB(37.19±5.25)g/L between the observation group and the control group(17.92±1.49)mmol/L and(36.79±6.13)g/L(P>0.05).The Hb(94.13±20.35)g/L and hospitalization days(24.25±5.39)d in the observation group were significantly lower than those in the control group(105.39±24.19)g/L and(31.19±4.52)d(P<0.05).The adverse reactions of patients with severe acute pancreatitis in the two groups were mainly focused on liver function injury,diarrhea,abdominal distension and abdominal infection.Finally,the total adverse reaction rate of patients with severe acute pancreatitis in the observation group(6.06%)was significantly lower than that in the control group(36.36%)(P<0.05).Before nursing,the SDS score(55.25±2.53)and SAS score(55.66±3.28)of the observation group were not significantly different from those of the control group(55.33±2.57)and SAS score(55.68±3.29)(P>0.05).After nursing,the SDS score(22.25±3.18)and SAS score(23.37±3.19)of the observation group were lower than those of the control group(35.22±3.21)and SAS score(35.25±3.14)(P<
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...